191 related articles for article (PubMed ID: 25060825)
1. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.
Wiltink LM; Chen TY; Nout RA; Kranenbarg EM; Fiocco M; Laurberg S; van de Velde CJ; Marijnen CA
Eur J Cancer; 2014 Sep; 50(14):2390-8. PubMed ID: 25060825
[TBL] [Abstract][Full Text] [Related]
2. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.
Chen TY; Wiltink LM; Nout RA; Meershoek-Klein Kranenbarg E; Laurberg S; Marijnen CA; van de Velde CJ
Clin Colorectal Cancer; 2015 Jun; 14(2):106-14. PubMed ID: 25677122
[TBL] [Abstract][Full Text] [Related]
3. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
Marijnen CA; van de Velde CJ; Putter H; van den Brink M; Maas CP; Martijn H; Rutten HJ; Wiggers T; Kranenbarg EK; Leer JW; Stiggelbout AM
J Clin Oncol; 2005 Mar; 23(9):1847-58. PubMed ID: 15774778
[TBL] [Abstract][Full Text] [Related]
4. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial.
Wiltink LM; Marijnen CA; Meershoek-Klein Kranenbarg E; van de Velde CJ; Nout RA
Acta Oncol; 2016; 55(4):502-8. PubMed ID: 26406287
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
[TBL] [Abstract][Full Text] [Related]
7. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
8. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
Kapiteijn E; Kranenbarg EK; Steup WH; Taat CW; Rutten HJ; Wiggers T; van Krieken JH; Hermans J; Leer JW; van de Velde CJ
Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
[TBL] [Abstract][Full Text] [Related]
10. A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study.
den Dulk M; Smit M; Peeters KC; Kranenbarg EM; Rutten HJ; Wiggers T; Putter H; van de Velde CJ;
Lancet Oncol; 2007 Apr; 8(4):297-303. PubMed ID: 17395102
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study.
Thong MS; Mols F; Lemmens VE; Rutten HJ; Roukema JA; Martijn H; van de Poll-Franse LV
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e49-58. PubMed ID: 21362582
[TBL] [Abstract][Full Text] [Related]
12. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial.
Tiv M; Puyraveau M; Mineur L; Calais G; Maingon P; Bardet E; Mercier M; Bosset JF
Cancer Radiother; 2010 Oct; 14(6-7):530-4. PubMed ID: 20797891
[TBL] [Abstract][Full Text] [Related]
14. Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer.
Doornebosch PG; Tollenaar RA; Gosselink MP; Stassen LP; Dijkhuis CM; Schouten WR; van de Velde CJ; de Graaf EJ
Colorectal Dis; 2007 Jul; 9(6):553-8. PubMed ID: 17573752
[TBL] [Abstract][Full Text] [Related]
15. Late side effects and quality of life after radiotherapy for rectal cancer.
Bruheim K; Guren MG; Skovlund E; Hjermstad MJ; Dahl O; Frykholm G; Carlsen E; Tveit KM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1005-11. PubMed ID: 19540058
[TBL] [Abstract][Full Text] [Related]
16. Effects of radiation and surgery on function and quality of life (QOL) in rectal cancer patients.
Wang L; Wang X; Lo A; Raval M; Brown C; Karimuddin A; Phang PT
Am J Surg; 2018 May; 215(5):863-866. PubMed ID: 29366486
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
[TBL] [Abstract][Full Text] [Related]
19. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for faecal incontinence after rectal cancer treatment.
Lange MM; den Dulk M; Bossema ER; Maas CP; Peeters KC; Rutten HJ; Klein Kranenbarg E; Marijnen CA; van de Velde CJ;
Br J Surg; 2007 Oct; 94(10):1278-84. PubMed ID: 17579345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
